Nicotinamide Riboside (NR)
NR · Niagen · Tru Niagen
Ancillary peptide Published Clinical Data
Overview
NAD+ precursor supplement. May also inhibit CD38 (NAD-degrading enzyme), offering dual benefit. 250–500mg daily. 2026 clinical trial showed equivalent NAD+ elevation to NMN. Some evidence NR partially converts to NMN in the gut — the distinction may be academic. Preferred by some for cost/availability.
Used in Regimens
Nicotinamide Riboside (NR) is not currently part of any catalog regimen.
Related Tools
Track Nicotinamide Riboside (NR) with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.